Lonicera hypoleuca
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Lonicera hypoleuca |
|---|---|
| Database Name | cmaup_plants;imppat_herbs;osadhi_herbs |
| Tropicos | http://www.tropicos.org/Name/50041098 |
| Pow | http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:148834-1 |
| Mpns Kew | https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=339733&query=Lonicera+hypoleuca+&filter=&fuzzy=false&nameType=all&dbs=wcsCmp |
| Synonyms | Lonicera hypoleuca, Yellow Himalayan Honeysuckle, Lonicera Hypoleuca |
| Ipni Id | http://www.ipni.org/ipni/idPlantNameSearch.do?id=148834-1&back_page=%2Fipni%2FeditSimplePlantNameSearch.do%3Ffind_wholeName%3DLonicera%2Bhypoleuca%2B%26output_format%3Dnormal, NPO3449 |
| Plant List Id | http://www.theplantlist.org/tpl1.1/record/tro-50041098 |
| Plant Name | Lonicera hypoleuca |
| Wfo | http://www.worldfloraonline.org/taxon/wfo-0001224258 |
| Genus Tax Id | 49606 |
| Disease Name | Ulcerative colitis, Solid tumour/cancer, Crohn disease, Inherited coagulation factor deficiency, HIV-infected patients with tuberculosis, Inflammatory spondyloarthritis, Type 2 diabetes mellitus, Hyper-lipoproteinaemia, Rheumatoid arthritis, Indeterminate colitis, Systemic sclerosis, Atopic eczema, Parasitic infection, Autonomic nervous system disorder, Chronic obstructive pulmonary disease, Cerebral ischaemia, Eye anterior segment structural developmental anomaly, Fungal infection, Nutritional deficiency, Asthma, Vasculitis, Postoperative inflammation, Cardiovascular disease, Migraine, Diabetes mellitus, type unspecified, Parkinsonism, Spinal pain, Mild neurocognitive disorder, Mood disorder, Multiple sclerosis, Neuropathy, Choreiform disorder, Reactive arthropathy, Female pelvic pain, Ataxic disorder, Seborrhoeic dermatitis, Osteoarthritis, Alzheimer disease, Lupus erythematosus, Colorectal cancer, Pain, unspecified, Psoriasis, Urinary system disease, Acute myeloid leukaemia, Acute/subacute hepatic failure, Skin and skin-structure infection, Myocardial infarction, Tonus and reflex abnormality, Otitis media, Joint pain, Irritable bowel syndrome, Endometriosis, Muscular dystrophy, Colon cancer, Genetic prion disease, Breast cancer, Sickle-cell disorder, Atrial fibrillation, Rectum cancer, Secondary progressive multiple sclerosis, Other specified non-alcoholic fatty liver disease, Chronic arterial occlusive disease, unspecified, Non-small cell lung cancer, Malignant neoplasms of colon, Obesity, Huntington disease, Squamous cell carcinoma of oropharynx, Prostate cancer, Male infertility, Periodontal disease, Leprosy, Polycystic ovary syndrome, Hypopituitarism, Metabolic disorder, Ageing associated decline in intrinsic capacity, Severe acute respiratory syndrome, Malignant neoplasm of pancreas, unspecified, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Endometrial cancer, Autosomal dominant polycystic kidney disease, Diffuse large B-cell lymphoma, Glioblastoma, primary, NOS, Breast in situ carcinoma, Acute viral hepatitis, Diabetes mellitus arising in pregnancy, COVID-19, Cervical cancer, Neuroendocrine carcinoma, Non-alcoholic fatty liver disease, Pulmonary hypertension, Intermediate hyperglycaemia, unspecified, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Central diabetes insipidus, Melanoma, Hypercholesterolaemia, Urogenital cancer, Head and neck cancer, Angiosarcoma, Other specified malignant neoplasms of colon, Neoplasms, Lipoatrophy/lipodystrophy, Neurobehavioral disorder, Squamous cell carcinoma, Columnar metaplastic epithelium of the oesophagus, unspecified, Fragile X chromosome, Obstructive sleep apnoea, Hidradenitis suppurativa, Large cell carcinoma of bronchus or lung, Adenocarcinoma, Unspecified malignant neoplasms of unspecified sites, Hepatocellular carcinoma, NOS, Chronic kidney disease, Endometrial glandular hyperplasia, Aneurysm/dissection, Primary neoplasms of brain, Dementia, Burn and burn infection, Multiple myeloma, Lung cancer, Disorders of intellectual development, unspecified, Bipolar disorder, Follicular lymphoma, Duchenne muscular dystrophy, Malignant neoplasm metastasis in male genital organs, Heart failure, Malaria, Malignant neoplasms of prostate, unspecified, Acute ischaemic heart disease, unspecified, Insulin-resistance syndromes, Polyneuropathy, unspecified, Type1diabetesmellitus, Generalised anxiety disorder, Diabetic foot ulcer, Sex development malformative disorder, Adenocarcinoma of prostate, Spastic cerebral palsy, Schizophrenia or other primary psychotic disorders, unspecified, Ovarian cancer, Becker muscular dystrophy, Pregnancy/childbirth/puerperium maternal infection, Carcinomas of ovary, Malignant neoplasms of bladder, unspecified, coronary artery disease, Thyroid cancer, Single episode depressive disorder, severe, without psychotic symptoms, Liver cancer, Inborn lipid metabolism error, Migraine disorder(TM1), Malignant neoplasm metastasis, unspecified, Schizophrenia, Macular degeneration, Small cell carcinoma of bronchus or lung, Blindness, Symptoms and signs involving cognition, unspecified, Precursor cell lymphoblastic leukaemia, NOS, Low back pain, Chronic lymphocytic leukaemia or small lymphocytic lymphoma, Adenocarcinoma, endocervical type, Neuropathic pain, Coronary atherosclerosis, Impaired glucose tolerance, Osteosarcoma of bone and articular cartilage of other specified sites, Malignant neoplasms of ill-defined sites, Primary progressive multiple sclerosis, Schizoaffective disorder, Glaucoma, Retinopathy, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Inflammatory bowel diseases, unspecified, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Hepatocellular carcinoma of liver, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Cytomegaloviral disease, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Malignant neoplasms of thymus, Glioblastoma of brain, Germ cell tumour of testis, Carpal tunnel syndrome, Malignant neoplasms of adrenal gland, Gliomas of brain |
| Genus Name | Lonicera |
| Disease Id | DD71, 2A00-2F9Z, DD70, 3B14, 1B10-1B14, FA92, 5A11, 5C80, FA20, DD72, 4A42, EA80, 1D0Y-1G2Z, 8D87, CA22, 8B1Z, LA11, 1F29-1F2F, 5B50-5B71, CA23, 4A44, 1A00-CA43, BA00-BE2Z, 8A80, 5A14, 8A00, ME84, 6D71, 6A60-6E23, 8A40, 8C0Z, 8A01, FA11, GA34, 8A03, EA81, FA00-FA05, 8A20, 4A40, 2B91, MG3Z, EA90, GC2Z, 2A60, DB91, 1F28-1G0Z, BA41-BA43, MB47, AA80-AB0Z, ME82, DD91, GA10, 8C70, 2B90, 8.00E+02, 2C60-2C6Y, 3A51, BC81.3, 2B92, 8A40.2, DB92.Y, BD4Z, 2C25, 5B80-5B81, 8A01.10, 2B6A.0, 2C82, GB04, DA0C, 1B20, 5A80.1, 5A61.0, 5C50-5D2Z, MG2A, 1D65, 2C10.Z, 1C62.Z, 2C76, GB81, 2A81, XH0MB1, 2.00E+65, 1.00E+50, JA63.2, 1D6Y, 2C77, 2C34, DB92, BB01, 5A40.Z, 2D60.0, 5A61.5, 2C30, 5C80.0, 2C95-2C9Z, 2D42, 2B56, 2B90.Y, 2, EF01, 8A00-8A0Z, 2B60-2D01, DA23.Z, LD55, 7A41, ED92, 2C25.3, 2D40, 2D4Z, XH4W48, GB61, GA16.0, BD50, 2A00, 6D80-6D8Z, ND90-NE2Z, 2A83, 6A00.Z, 6A60, 2A80, 8C70.1, 2.00E+06, BD10-BD1Z, 1F40-1F45, 2C82.Z, BA4Z, 5A44, 5A10, 6B00, BD54, LD2A, 2C82.0, 8D20, 6A2Z, 2C73, 8C70.0, JB63, 2C73.0, 2C94.Z, BA8Y-BA8Z, 2D10, 6A70.3, 2C12, 5C52, SD10, 2E2Z, 6A20, 9B75, 2C25.1, 9D90.6, MB21.Z, XH5J37, ME84.2, 2A82.0, XH0GS9, 8E43.0, BA80, 5A40.1, 2B51.Y, 8A40.1, 6A21, 9C61, 9B71, 2C76.43, 2C73.4, XH3854, DD7Z, FA0Z, 2C15, 2C12.01, 1F54, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2C12.02, GA10.B4, 2B70, 1D82, 2D10.Z, 2C76.Z, 1D40, 2C27, 2A00.00, 2C80.2, 8C10.0, 2D11, 2A00.0 |
| Family Name | Caprifoliaceae |
| Family Tax Id | 4200 |
| Group | Angiosperms |
- 1. (+)-Aromadendrene (PubChem CID: 11095734)
- 2. (-)-Abscisic Acid (PubChem CID: 643732)
- 3. (-)-Alpha-Curcumene (PubChem CID: 442360)
- 4. (-)-Alpha-Pinene (PubChem CID: 440968)
- 5. (-)-Beta-Sitosterol (PubChem CID: 6432744)
- 6. (1r,2r)-1,8,10-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-9-(3-Methylbut-2-Enyl)-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 163186423)
- 7. (1r,3r,4s,5s)-3-[(E)-3-(3,4-Dihydroxyphenyl)prop-2-Enoyl]oxy-1,4,5-Trihydroxycyclohexane-1-Carboxylic Acid (PubChem CID: 11870310)
- 8. (2r)-2,6,11-Trihydroxy-3,3,9-Trimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163069831)
- 9. (2r)-2-[3-[(E)-2-[(2s,3r,4s)-5-Carboxy-3-Ethenyl-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-3,4-Dihydro-2h-Pyran-4-Yl]ethenyl]pyridin-1-Ium-1-Yl]-3-Phenylpropanoate (PubChem CID: 76309955)
- 10. (2r)-4-Hydroxy-2-(2-Hydroxypropan-2-Yl)-7,8-Dimethoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163048406)
- 11. (2r,3s)-2-(3,5-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 6325418)
- 12. (2s)-2,6,9,11-Tetrahydroxy-3,3-Dimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163048792)
- 13. (2s)-2-[3-[(E)-2-[(2s,3r,4s)-3-Ethenyl-5-Methoxycarbonyl-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-3,4-Dihydro-2h-Pyran-4-Yl]ethenyl]pyridin-1-Ium-1-Yl]propanoate (PubChem CID: 76335389)
- 14. (2s)-2-[3-[(E)-2-[(2s,3r,4s)-5-Carbamoyl-3-Ethenyl-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-3,4-Dihydro-2h-Pyran-4-Yl]ethenyl]pyridin-1-Ium-1-Yl]-5-Hydroxy-5-Oxopentanoate (PubChem CID: 76328124)
- 15. (2s)-4,7-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-11-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163007755)
- 16. (2s)-4,7-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 154496056)
- 17. (2s)-4,8,10-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-9-(3-Methylbut-2-Enyl)-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 162980002)
- 18. (2s)-4,8,10-Trihydroxy-9-(3-Methylbut-2-Enyl)-2-Prop-1-En-2-Yl-1,2-Dihydrofuro[3,2-A]xanthen-11-One (PubChem CID: 163031668)
- 19. (2s)-4,8-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-7-Methoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 162957066)
- 20. (2s)-4,8-Dihydroxy-7-Methoxy-6-(3-Methylbut-2-Enyl)-2-Prop-1-En-2-Yl-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 163087336)
- 21. (2s)-4,9-Dihydroxy-2-(2-Hydroxypropan-2-Yl)-11-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 162987335)
- 22. (2s,3r)-3,4,8-Trihydroxy-2-(2-Hydroxypropan-2-Yl)-7-Methoxy-6-(3-Methylbut-2-Enyl)-2,3-Dihydrofuro[3,2-B]xanthen-5-One (PubChem CID: 11546716)
- 23. (2s,3r,4s)-4-[(E)-2-[5-Carboxy-1-[(1s,2s)-1-Carboxy-2-Methylbutyl]pyridin-1-Ium-3-Yl]ethenyl]-3-Ethenyl-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-3,4-Dihydro-2h-Pyran-5-Carboxylate (PubChem CID: 76317186)
- 24. (2s,3s)-2,3,8-Trihydroxy-6-Methoxy-7-(3-Methylbut-2-Enyl)-1,2,3,4-Tetrahydroxanthen-9-One (PubChem CID: 163065723)
- 25. (3beta,23e)-3-Hydroxy-9,19-Cyclo-27-Norlanost-23-En-25-One (PubChem CID: 21626061)
- 26. (3r)-3,9-Dihydroxy-5,10-Dimethoxy-2,2-Dimethyl-11-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[2,3-A]xanthen-12-One (PubChem CID: 163082788)
- 27. (3r)-5,8-Dihydroxy-3-Methyl-3,4-Dihydroisochromen-1-One (PubChem CID: 10442609)
- 28. (3r)-8-Hydroxy-3-Methyl-3,4-Dihydro-1h-2-Benzopyran-1-One (PubChem CID: 114679)
- 29. (3r,6e)-Nerolidol (PubChem CID: 11241545)
- 30. (3s)-3,5,9-Trihydroxy-10-Methoxy-2,2-Dimethyl-11-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[2,3-A]xanthen-12-One (PubChem CID: 162842817)
- 31. (3s)-3,5,9-Trihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-2-Enyl)-3,4-Dihydropyrano[3,2-B]xanthen-6-One (PubChem CID: 92448128)
- 32. (3s,4as,6ar,6bs,8ar,12ar,14as,14br)-3-Hydroxy-4,4,6a,6b,8a,11,11,14b-Octamethyl-3,4a,5,6,7,8,9,10,12,12a,14,14a-Dodecahydro-2h-Picen-1-One (PubChem CID: 14194115)
- 33. (3s,4s)-4-Acetyl-3-Methyloxolan-2-One (PubChem CID: 118708002)
- 34. (4s,8r)-8,14-Dihydroxy-16-Methoxy-4-Methyl-3-Oxabicyclo[10.4.0]hexadeca-1(12),13,15-Trien-2-One (PubChem CID: 134142479)
- 35. (5r) 5-Hydroxylasiodiplodin (PubChem CID: 10638525)
- 36. (5s) 5-Hydroxylasiodiplodin (PubChem CID: 10733600)
- 37. (6r)-15-Hydroxy-9-Methoxy-19,19-Dimethyl-6-Propan-2-Yl-7,12,20-Trioxapentacyclo[11.8.0.03,11.04,8.016,21]henicosa-1(13),3,8,10,14,16(21)-Hexaen-2-One (PubChem CID: 162875726)
- 38. (E)-Jasmone (PubChem CID: 1549019)
- 39. (E,6s)-6-[(1s,3r,7s,8r,11s,12s,15r,16r)-7-Hydroxy-7,12,16-Trimethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-3-En-2-One (PubChem CID: 162908349)
- 40. 1(3h)-Isobenzofuranone, 3-Butylidene- (PubChem CID: 62368)
- 41. 1,2-Dihydroxy-6-Methylanthracene-9,10-Dione (PubChem CID: 5319503)
- 42. 1,3,6,7-Tetrahydroxy-8-Prenylxanthone (PubChem CID: 15307924)
- 43. 1,3,6-Trihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-7-Methoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 156908054)
- 44. 1,3,7-Trihydroxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methylbutyl)-Xanthone (PubChem CID: 102234393)
- 45. 1,3,7-Trihydroxy-2-Methoxyxanthone (PubChem CID: 12133315)
- 46. 1,3,7-Trihydroxy-2-Prenylxanthone (PubChem CID: 5495920)
- 47. 1,3,7-Trihydroxy-6-Methyl-2,8-Bis(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163003410)
- 48. 1,3-Dihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-6,7-Dimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162924938)
- 49. 1,4,5,6-Tetrahydroxy-2-(2-Methylbut-3-En-2-Yl)xanthen-9-One (PubChem CID: 10426622)
- 50. 1,5,8-Trihydroxy-3-Methyl-2,4-Bis(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162980068)
- 51. 1,5-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 10449043)
- 52. 1,6,7-Trihydroxy-8-(3-Hydroxy-3-Methylbutyl)-3-Methyl-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162851978)
- 53. 1,6-Dihydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,7-Dimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162962935)
- 54. 1,6-Dihydroxy-3,7-Dimethoxy-2-(3-Methyl-2-Butenyl)-8-(2-Oxo-3-Methyl-3-Butenyl)-Xanthone (PubChem CID: 129847853)
- 55. 1,6-Dihydroxy-3,7-Dimethoxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methyl-1e-Butenyl)-Xanthone (PubChem CID: 5319262)
- 56. 1,6-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 14162675)
- 57. 1,6-Dihydroxy-8-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,7-Dimethoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162871148)
- 58. 1,7-Dihydroxy-3-Methoxy-2-Prenylxanthone (PubChem CID: 509269)
- 59. 1,8-Dihydroxy-3-Methoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162890971)
- 60. 1-(3,3-Dimethylbutyl)-3,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 89172625)
- 61. 1-[(2s)-2,3-Dihydroxy-3-Methylbutyl]-3,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163010748)
- 62. 1-Hexanol (PubChem CID: 8103)
- 63. 1-Hydroxy-2-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,6,7-Trimethoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162956670)
- 64. 1-Hydroxy-3,6,7-Trimethoxy-2-(3-Methyl-2-Butenyl)-8-(3-Hydroxy-3-Methyl-1e-Butenyl)-Xanthone (PubChem CID: 5319715)
- 65. 1-Hydroxy-8-[(2r)-2-Hydroxy-3-Methylbut-3-Enyl]-3,6,7-Trimethoxy-2-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 163021718)
- 66. 1-Isomangostin (PubChem CID: 5281641)
- 67. 10,22-Dihydroxy-7,7,18,18-Tetramethyl-8,13,17-Trioxapentacyclo[12.8.0.03,12.04,9.016,21]docosa-1(22),3(12),4(9),10,14,16(21),19-Heptaen-2-One (PubChem CID: 56840488)
- 68. 11alpha-Mangostanin (PubChem CID: 46880204)
- 69. 2,4,6,3',5'-Pentahydroxybenzophenone (PubChem CID: 19910294)
- 70. 2,4-Dimethylbenzaldehyde (PubChem CID: 61814)
- 71. 2-(1,1-Dimethyl-2-Propenyl)-1,4,5-Trihydroxy-9h-Xanthen-9-One (PubChem CID: 364825)
- 72. 2-(3,7-Dimethylocta-2,6-Dienyl)-1,3,5,8-Tetrahydroxyxanthen-9-One (PubChem CID: 72988981)
- 73. 2-(3,7-Dimethylocta-2,6-Dienyl)-1,3,5-Trihydroxyxanthen-9-One (PubChem CID: 5495932)
- 74. 2-[(2r)-2,3-Dimethylbut-3-Enyl]-1,3,6-Trihydroxy-7-Methoxy-8-(3-Methylbut-2-Enyl)xanthen-9-One (PubChem CID: 162852100)
- 75. 2-[4,6,8-Trihydroxy-2-Methoxy-7-(3-Methylbut-2-Enyl)-9-Oxoxanthen-1-Yl]acetaldehyde (PubChem CID: 163088729)
- 76. 2-Furanmethanol, 5-Ethenyltetrahydro-Alpha,alpha,5-Trimethyl- (PubChem CID: 22310)
- 77. 2-Methyl-1-Butanol (PubChem CID: 8723)
- 78. 2-Nonadecanone (PubChem CID: 69423)
- 79. 2-Pentadecanone (PubChem CID: 61303)
- 80. 3',6-Dihydroxy-2,4,4'-Trimethoxybenzophenone (PubChem CID: 101763992)
- 81. 3,4,5,3'-Tetrahydroxybenzophenone (PubChem CID: 52948815)
- 82. 3,5,9-Trihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-2-Enyl)pyrano[3,2-B]xanthen-6-One (PubChem CID: 68229267)
- 83. 3,6-Dimethylmangostin (PubChem CID: 231412)
- 84. 3-Ethyl-4-Methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]pyrrole-2,5-Dione (PubChem CID: 100933901)
- 85. 3-Ethylpyridine (PubChem CID: 10823)
- 86. 3-Hexenol (PubChem CID: 5281167)
- 87. 3-Isomangostin (PubChem CID: 13873655)
- 88. 3-Vinylpyridine (PubChem CID: 14272)
- 89. 4,8-Dihydroxy-7-Methoxy-6-(3-Methylbut-2-Enyl)furo[3,2-B]xanthen-5-One (PubChem CID: 162846027)
- 90. 4-Hydroxy-7,8-Dimethoxy-6-(3-Methylbut-2-Enyl)furo[3,2-B]xanthen-5-One (PubChem CID: 101193830)
- 91. 5,8,9-Trihydroxy-2,2-Dimethyl-10-(3-Methylbut-2-Enyl)pyrano[3,2-B]xanthen-6-One (PubChem CID: 10046140)
- 92. 5,9,11-Trihydroxy-3,3-Dimethyl-10-(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 11696901)
- 93. 5,9,11-Trihydroxy-3,3-Dimethyl-6,10-Bis(3-Methylbut-2-Enyl)-1,2-Dihydropyrano[3,2-A]xanthen-12-One (PubChem CID: 163091100)
- 94. 5,9-Dihydroxy-2,2,11,11-Tetramethyl-8-(3-Methyl-2-Butenyl)-2h-Dipyrano[2,3-A:2',3'-J]xanthen-14(11h)-One (PubChem CID: 71437595)
- 95. 5,9-Dihydroxy-8-Methoxy-2,2-Dimethyl-7-(3-Methylbut-3-Enyl)-3,4-Dihydropyrano[3,2-B]xanthen-6-One (PubChem CID: 163013585)
- 96. 5-(3,3-Dimethyloxiran-2-Yl)-3-Methylpent-1-En-3-Ol (PubChem CID: 529304)
- 97. 5-Hydroxy-8-[5-Hydroxy-7-Methoxy-2-(4-Methoxyphenyl)-4-Oxochromen-8-Yl]-7-Methoxy-2-(4-Methoxyphenyl)chromen-4-One (PubChem CID: 11103936)
- 98. 5-P-Coumaroylquinic Acid, (Z)- (PubChem CID: 90478782)
- 99. 6-Deoxy-Gamma-Mangostin (PubChem CID: 13873657)
- 100. 6-Methylsalicylic Acid (PubChem CID: 11279)
- 101. 7-Methoxy-2-(3-Methyl-2-Butenyl)-8-(3-Methyl-2-Oxo-3-Butenyl)-1,3,6-Trihydroxyxanthone (PubChem CID: 69074110)
- 102. 8-Deoxygartanin (PubChem CID: 392450)
- 103. 8-Epiloganic Acid (PubChem CID: 158144)
- 104. 8-Hydroxycudraxanthone G (PubChem CID: 11711264)
- 105. 9-Hydroxycalabaxanthone (PubChem CID: 5495929)
- 106. 9-Hydroxycalabaxanthone Hydrate (PubChem CID: 56840489)
- 107. [(E)-Hex-1-Enyl] Benzoate (PubChem CID: 15193511)
- 108. [2,4-Dihydroxy-6-[(2s,3s,4s,5s,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyphenyl]-Phenylmethanone (PubChem CID: 162864269)
- 109. Alpha-Hederin (PubChem CID: 73296)
- 110. Anthragallol (PubChem CID: 11768)
- 111. Apigetrin (PubChem CID: 5280704)
- 112. Astilbin (PubChem CID: 119258)
- 113. Avicularin (PubChem CID: 5490064)
- 114. Benzaldehyde (PubChem CID: 240)
- 115. Beta-Ionone (PubChem CID: 638014)
- 116. Beta-Mangostin (PubChem CID: 5495925)
- 117. Beta-Pinene (PubChem CID: 14896)
- 118. Beta-Sitosterol (PubChem CID: 222284)
- 119. Bornyl Acetate, (-)- (PubChem CID: 93009)
- 120. Botryosphaeridione (PubChem CID: 44605081)
- 121. Botryosphaerihydrofuran (PubChem CID: 44605288)
- 122. Botryosphaerilactone A (PubChem CID: 102161309)
- 123. Botryosphaerilactone B (PubChem CID: 44605080)
- 124. Botryosphaerilactone C (PubChem CID: 102161308)
- 125. Botryosphaerinone (PubChem CID: 102161310)
- 126. Br-Xanthone A (PubChem CID: 13964005)
- 127. Br-Xanthone B (PubChem CID: 14034125)
- 128. Brasilixanthone B (PubChem CID: 5324261)
- 129. Campesterol (PubChem CID: 173183)
- 130. Carneic Acid B (PubChem CID: 16083153)
- 131. Carvacrol (PubChem CID: 10364)
- 132. Caryophyllene (PubChem CID: 5281515)
- 133. Chryseriol (PubChem CID: 5280666)
- 134. Cianidanol (PubChem CID: 9064)
- 135. Cis-4-Hydroxymellein (PubChem CID: 10420140)
- 136. Cowagarcinone B (PubChem CID: 5316764)
- 137. Cratoxyxanthone (PubChem CID: 46879489)
- 138. Cudraxanthone G (PubChem CID: 42645953)
- 139. Demethylcalabaxanthone (PubChem CID: 509270)
- 140. Digitoxigenin (PubChem CID: 4369270)
- 141. Dihydro-4-(Hydroxymethyl)-3,5-Dimethyl-2 (PubChem CID: 102125217)
- 142. Dulxanthone D (PubChem CID: 10405091)
- 143. Egonol (PubChem CID: 485186)
- 144. Epicatechin (PubChem CID: 72276)
- 145. Euxanthone (PubChem CID: 5281631)
- 146. Farnesol, (2z,6z)- (PubChem CID: 1549107)
- 147. Gamma-Mangostin (PubChem CID: 5464078)
- 148. Garcimangosone A (PubChem CID: 10874207)
- 149. Garcimangosone B (PubChem CID: 11143989)
- 150. Garcimangosone D (PubChem CID: 11003703)
- 151. Garcinone A (PubChem CID: 70689919)
- 152. Garcinone B (PubChem CID: 5495928)
- 153. Garcinone C (PubChem CID: 44159808)
- 154. Garcinone D (PubChem CID: 5495926)
- 155. Garcinone E (PubChem CID: 10298511)
- 156. Gartanin (PubChem CID: 5281633)
- 157. Gentisein (PubChem CID: 5281635)
- 158. Ginnol (PubChem CID: 16057860)
- 159. Hederagenin (PubChem CID: 73299)
- 160. Heptacosane (PubChem CID: 11636)
- 161. Heptadecanoic Acid (PubChem CID: 10465)
- 162. Hexenyl Tiglate, (3z)- (PubChem CID: 15461361)
- 163. Hyperoside (PubChem CID: 5281643)
- 164. Indole (PubChem CID: 798)
- 165. Isopropyl Dodecanoate (PubChem CID: 25068)
- 166. Isoquercetin (PubChem CID: 5280804)
- 167. Jasmone (PubChem CID: 1549018)
- 168. L-Menthyl Acetate (PubChem CID: 220674)
- 169. Lasiodiplodin (PubChem CID: 14562696)
- 170. Lasiolactone (PubChem CID: 89352705)
- 171. Linalool, (+)- (PubChem CID: 67179)
- 172. Lonijaposide C (PubChem CID: 24879106)
- 173. Lonijaposide J (PubChem CID: 56599869)
- 174. Lonijaposide M (PubChem CID: 56599874)
- 175. Macluraxanthone (PubChem CID: 5281646)
- 176. Maclurin (PubChem CID: 68213)
- 177. Mangostenone A (PubChem CID: 509267)
- 178. Mangostenone B (PubChem CID: 21672078)
- 179. Mangostin (PubChem CID: 5281650)
- 180. Mangostinone (PubChem CID: 6478778)
- 181. Metformin (PubChem CID: 4091)
- 182. Methyl Benzoate (PubChem CID: 7150)
- 183. Methyl Pentadecanoate (PubChem CID: 23518)
- 184. Methyl Tetracosanoate (PubChem CID: 75546)
- 185. Morindone (PubChem CID: 442756)
- 186. Nerol (PubChem CID: 643820)
- 187. Norathyriol (PubChem CID: 5281656)
- 188. O-Demethylforbexanthone (PubChem CID: 45269778)
- 189. Ochnaflavone (PubChem CID: 5492110)
- 190. Octyl Acetate (PubChem CID: 8164)
- 191. P-Coumaric Acid (PubChem CID: 637542)
- 192. Palmitic Acid (PubChem CID: 985)
- 193. Pentadecanoic Acid (PubChem CID: 13849)
- 194. Phthalic Anhydride (PubChem CID: 6811)
- 195. Pleconaril (PubChem CID: 1684)
- 196. Proanthocyanidin A1 (PubChem CID: 9872976)
- 197. Procyanidin A2 (PubChem CID: 124025)
- 198. Procyanidin B2, (+)- (PubChem CID: 122738)
- 199. Procyanidin B5 (PubChem CID: 124017)
- 200. Quosp (PubChem CID: 5282166)
- 201. Rubraxanthone (PubChem CID: 9953366)
- 202. Rutin (PubChem CID: 5280805)
- 203. Scopoletin (PubChem CID: 5280460)
- 204. Secologanin (PubChem CID: 161276)
- 205. Secoxyloganin Methyl Ester (PubChem CID: 14105070)
- 206. Sitogluside (PubChem CID: 5742590)
- 207. Smeathxanthone A (PubChem CID: 11509473)
- 208. Swertiamarin (PubChem CID: 442435)
- 209. Syringic Acid (PubChem CID: 10742)
- 210. Tetrahydro-4-Hydroxy-6-Propylpyran-2-One (PubChem CID: 130907047)
- 211. Thwaitesixanthone (PubChem CID: 392169)
- 212. Tovophyllin A (PubChem CID: 42645954)
- 213. Tovophyllin B (PubChem CID: 509268)
- 214. Trans-3-Hexen-1-Ol (PubChem CID: 5284503)
- 215. Trans-4-Hydroxymellein (PubChem CID: 10262028)
- 216. Trapezifolixanthone (PubChem CID: 188341)
- 217. Triacontane (PubChem CID: 12535)
- 218. Trigonelline (PubChem CID: 5570)
- 219. Undecanedioic Acid (PubChem CID: 15816)
- 220. Ursonic Acid (PubChem CID: 9890209)
- 221. Vibsanin P (PubChem CID: 643712)
- 222. Vibsanin T (PubChem CID: 11441439)
- 1. Adenocarcinoma
- 2. Alzheimer's Disease 1
- 3. Arthritis, Rheumatoid
- 4. Asthma
- 5. Cardiovascular Diseases
- 6. Cholera
- 7. Coronary Artery Disease
- 8. Crohn Disease
- 9. Dementia
- 10. Diabetes Insipidus
- 11. Diabetes Mellitus
- 12. Diabetes Mellitus, Type 1
- 13. Glaucoma
- 14. Infertility, Male
- 15. Inflammatory Bowel Diseases
- 16. Leprosy
- 17. Liver Neoplasms
- 18. Muscular Dystrophies
- 19. Myocardial Infarction
- 20. Neoplasms
- 21. Obesity
- 22. Osteoarthritis
- 23. Psoriasis
- 24. Scleroderma, Systemic
- 25. Spondylitis
- 26. Urinary Bladder Neoplasms
- 27. Urinary System Disease
- 1. Aravind
- 2. Ashtangavaleha
- 3. Citraka Haritaki
- 4. Cyavanaprasa
- 5. Dasamula Haritaki
- 6. Dasamularista
- 7. Draksavaleha
- 8. Eladi Gutika
- 9. Kanakasava
- 10. Kumaryasava
- 11. Kusmandaka Rasayana
- 12. Lohasava
- 13. Madhusnuhi Rasayana
- 14. Mrdvikadi Lehya
- 15. Narasimha Curna
- 16. Punarnavasava
- 17. Suranavaleha
- 18. Usirasava
- 19. Vasavaleha
- 20. Vyaghri Haritaki